Class IITerminated in FDA datasetMay 15, 2019

Immulox

Recalling firm: APS BioGroup, Inc

Why it was recalled

The recall is being conducted as a result of elevated APC levels. Through additional testing, it was determined that the organism is Stenotrophomonas maltophilia.

Check the codes ↓

The exact product

Immulox, UPC 1 82863 000064 6. Immune Balance Polypeptide Supplement with Naturally Occuring Bioactive Peptides. 5.07 oz (150 ml)

Check the codes

Compare these FDA-provided codes, lot numbers or dates with the product you have.

Match the product, size and code together. A similar name alone does not identify your batch.

Original FDA code information

Manufactured April 21, 2019. Lot 9068-2, Item # 4044, Bulk # UL-7, Exp. Date 04/2021; Lot 9068-3, Item # 4691, Bulk # UL-7, Exp. Date 04/2021; Lot 9068-4, Item # 4181, Bulk # UL-7, Exp. Date 04/2021; Lot 9068-5, Item # 00064, Bulk # UL-7, Exp. Date 04/2021; Lot 9068-6, Item # 00064, Bulk # UL-7, Exp. Date 04/2021

Recall details

Recall number
F-1481-2019
Event ID
82900
FDA status
Terminated
Initiated
May 15, 2019
Reported
Jun 26, 2019
Classified
Jun 18, 2019
Terminated
Dec 27, 2019
Quantity
7,132 Total Units
Location
Phoenix, AZ, United States
Initiation type
Voluntary: Firm initiated
Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Where it was distributed

Nationwide and Switzerland. No military/govt/VA consignees.

FDA source record · F-1481-2019

Data updated September 16, 2026. View official FDA data ↗

A missing code match is not a guarantee of safety. Follow official FDA and manufacturer guidance.